Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of Ridaforolimus on the Pharmacokinetics of Midazolam (Study MK-8669-044)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.
ClinicalTrials.gov Identifier:
NCT01071304
First received: February 17, 2010
Last updated: April 9, 2015
Last verified: April 2015